March 6, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, announces today that it has received a major order from BML, Inc. (BioMedical Laboratories), the biggest Japanese private laboratory chain. bioMérieux will supply 28 VITEK® 2 XL to BML.
bioMérieux, a global leader in the field of in vitro diagnostics, announces today that it has received a major order from BML, Inc. (BioMedical Laboratories), the biggest Japanese private laboratory chain. bioMérieux will supply 28 VITEK® 2 XL to BML.
bioMérieux confirmed today that BML, a major Japanese company, has placed an order for 28 VITEK® 2 XL. The VITEK® 2 technology enables fully automated microbial identification and antibiotic susceptibility testing (ID/AST).
This technology offers faster results for relevant antibiotic therapy, thereby limiting the risk of therapeutic failure. For more than 40 years, bioMérieux has been committed to delivering relevant microbiology solutions to empower clinical decisions. bioMérieux’s objective has always been to find new and better ways of improving overall patient care.
“We are very proud that BML has chosen our technology to equip its laboratories. This major order reinforces our leadership in microbiology and our ability to increase our business growth in Japan as highlighted in our strategy” affirms Stéphane Bancel, Chief Executive Officer, bioMérieux.
The order will be booked upon the installation of the instruments, in late quarter 2 or early quarter 3, 2007.
Founded some 40 years ago, BML is an all-inclusive laboratory, offering a wide range of services such as special laboratory testing and investigative research. BML is committed to contribute to the progress of medical practice and to provide superior clinical testing systems for improved patient health. The company is also expanding in fields such as food hygiene testing, environmental analysis and genetic analysis. Information on BML can be found at http://www.bml.jp.